Xiaobo Yang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Haitao Zhao (75 shared papers)Xinting Sang (54 shared papers)Jianzhen Lin (30 shared papers)Junyu Long (34 shared papers)Yi Bai (16 shared papers)Anqiang Wang (16 shared papers)Dongxu Wang (16 shared papers)Bo Hu (7 shared papers)
- Journals
- Cancer Immunology Immunotherapy (8 papers)World Journal of Gastroenterology (7 papers)Oncotarget (5 papers)Annals of Translational Medicine (4 papers)Frontiers in Immunology (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaobo Yang
98 papers receiving 2.7k citations
Xiaobo Yang's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 771
- Hepatology 331
- Oncology 770
- Pulmonary and Respiratory Medicine 482
- Immunology 256
Countries citing papers authored by Xiaobo Yang
This map shows the geographic impact of Xiaobo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Yang more than expected).
Fields of papers citing papers by Xiaobo Yang
This network shows the impact of papers produced by Xiaobo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Yang. The network helps show where Xiaobo Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma Hit paper breakdown → | 2019 | 256 |
| 2 | 2020 | 115 | |
| 3 | 2020 | 114 | |
| 4 | 2014 | 108 | |
| 5 | 2019 | 101 | |
| 6 | 2020 | 100 | |
| 7 | 2019 | 87 | |
| 8 | 2017 | 84 | |
| 9 | 2019 | 83 | |
| 10 | 2019 | 72 | |
| 11 | 2016 | 69 | |
| 12 | 2016 | 67 | |
| 13 | 2015 | 60 | |
| 14 | 2018 | 58 | |
| 15 | 2011 | 57 | |
| 16 | 2020 | 49 | |
| 17 | T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy. | 2020 | 49 |
| 18 | 2024 | 48 | |
| 19 | 2011 | 47 | |
| 20 | 2020 | 45 |
About Xiaobo Yang
Xiaobo Yang is a scholar working on Surgery, Oncology, Molecular Biology, Hepatology and Cancer Research, having authored 99 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers), RNA modifications and cancer (12 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Mechanisms and Therapy (8 papers), Cancer-related molecular mechanisms research (7 papers), Ferroptosis and cancer prognosis (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Cancer Research (771 citations), Hepatology (331 citations), Oncology (770 citations), Pulmonary and Respiratory Medicine (482 citations) and Immunology (256 citations). Xiaobo Yang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Haitao Zhao, Xinting Sang, Jianzhen Lin, Junyu Long, Yi Bai, Anqiang Wang, Dongxu Wang, Bo Hu, Xu Yang and Xueshuai Wan. Their work appears in journals such as Cancer Immunology Immunotherapy, World Journal of Gastroenterology, Oncotarget, Annals of Translational Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.